---
title: "Crescent Biopharma (CBIO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CBIO.US/norm.md"
symbol: "CBIO.US"
name: "Crescent Biopharma"
parent: "https://longbridge.com/en/quote/CBIO.US.md"
datetime: "2026-03-08T05:38:33.724Z"
locales:
  - [en](https://longbridge.com/en/quote/CBIO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CBIO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CBIO.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CBIO.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CBIO.US/norm.md)


# Crescent Biopharma (CBIO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -4.01 | -1.27 | -4.93 | -18.39 | -19.74 |
| ROE | -237.18% | -79.41% | -165.87% | - | - |
| Revenue | 10.84M | - | - | - | - |
| Net income | -92.40M | -24.61M | -21.79M | -15.15M | -15.24M |
| Operating income | -91.49M | -25.89M | -21.03M | -14.22M | -14.56M |
| Gross margin | 100.00% | - | - | - | - |
| Net margin | -852.06% | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 240.29M | 138.27M | 157.43M | 25.61M | 35.62M |
| Leverage | 1.18 | 1.19 | 1.13 | -0.9787 | -3.10 |
| BVPS | 5.99 | 5.76 | 6.92 | -4.28 | -2.20 |
| Turnover | 0.0786 | - | - | - | - |
| Cash & STI | 213.19M | 133.26M | 152.65M | 22.43M | 34.77M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 2.31M | 2.35M | 1.80M | - | - |
| Net debt | -211.55M | -131.52M | -151.00M | 15.05M | 2.72M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -26.74M | -17.54M | -16.40M | -10.85M | - |
| Investing CF | -72.19M | -586000.00 | -140000.00 | - | - |
| Financing CF | 178.86M | -1.25M | 146.86M | -1.49M | - |
| Free CF | -130.99M | -11.12M | -6.86M | - | - |
| OCF coverage | -13854.92% | -2993.00% | -11715.71% | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | -193000.00 | -586000.00 | -140000.00 | - | - |

## Distribution Plan

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.24USD | 2023-01-05 | 2023-01-13 | 2023-01-12 |
| Cash Dividend: 
1.43USD | 2022-09-06 | 2022-09-21 | 2022-09-20 |
| Cash Dividend: 
0.5692USD | 2015-08-14 | 2015-08-20 | 2015-08-19 |